Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection - PubMed
4 hours ago
- #CKM syndrome
- #SGLT-2 inhibitors
- #renal protection
- Cardiovascular-kidney-metabolic (CKM) diseases are a major global health challenge.
- Sodium-glucose cotransporter-2 (SGLT-2) inhibitors play a critical role in renal protection and managing metabolic and cardiovascular disorders.
- The review highlights the complex interplay among type 2 diabetes, cardiovascular disease, and chronic kidney disease.
- Early intervention and comprehensive management are essential for improving patient outcomes and reducing healthcare strain.
- The review also discusses challenges in managing CKM syndrome and suggests future directions, particularly in China.